Total Payments
$19,181
2024 Payments
$2,605
Companies
81
Transactions
1,190
Medicare Patients
2,438
Medicare Billing
$166,720
Payment Breakdown by Category
Food & Beverage$19,154 (99.9%)
Education$27.06 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $19,154 | 1,186 | 99.9% |
| Education | $27.06 | 4 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,772 | 161 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,316 | 131 | $0 (2024) |
| Novo Nordisk Inc | $1,891 | 126 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,578 | 100 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,184 | 69 | $0 (2024) |
| Lilly USA, LLC | $1,149 | 90 | $0 (2024) |
| PFIZER INC. | $1,123 | 94 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,022 | 65 | $0 (2024) |
| Merck Sharp & Dohme LLC | $461.07 | 36 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $457.96 | 26 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,605 | 146 | ABBVIE INC. ($717.72) |
| 2023 | $2,667 | 162 | AbbVie Inc. ($601.36) |
| 2022 | $2,818 | 161 | ABBVIE INC. ($665.00) |
| 2021 | $2,826 | 173 | AbbVie Inc. ($534.42) |
| 2020 | $1,813 | 112 | AstraZeneca Pharmaceuticals LP ($394.06) |
| 2019 | $2,345 | 148 | GlaxoSmithKline, LLC. ($293.62) |
| 2018 | $2,011 | 145 | AstraZeneca Pharmaceuticals LP ($252.90) |
| 2017 | $2,095 | 143 | Janssen Pharmaceuticals, Inc ($378.66) |
All Payment Transactions
1,190 individual payment records from CMS Open Payments — Page 1 of 48
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.84 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: DIABETES | ||||||
| 12/16/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Neuroscience | ||||||
| 12/10/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $25.69 | General |
| Category: PSYCHIATRY | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: DIABETES | ||||||
| 12/06/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $25.26 | General |
| Category: RESPIRATORY | ||||||
| 12/06/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.29 | General |
| Category: Endocrinology | ||||||
| 12/05/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.93 | General |
| Category: NEUROSCIENCE | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.40 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2024 | ABBVIE INC. | VIBERZI (Drug), CREON | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: DIABETES | ||||||
| 11/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: Inflammation | ||||||
| 11/20/2024 | Cranial Technologies, Inc | Doc Band (Device) | Food and Beverage | Cash or cash equivalent | $8.75 | General |
| Category: Cranial Orthotic | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $32.44 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $6.93 | General |
| Category: DIABETES | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $13.90 | General |
| Category: VACCINES | ||||||
| 11/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $6.97 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: NEUROSCIENCE | ||||||
| 11/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $9.10 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Endocrinology | ||||||
| 11/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 592 | 749 | $135,846 | $39,730 |
| 2022 | 14 | 607 | 823 | $122,565 | $34,571 |
| 2021 | 21 | 703 | 957 | $133,757 | $53,162 |
| 2020 | 12 | 536 | 772 | $92,865 | $39,256 |
Total Patients
2,438
Total Services
3,301
Medicare Billing
$166,720
Procedure Codes
61
All Medicare Procedures & Services
61 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 120 | 221 | $57,902 | $11,448 | 19.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 25 | 25 | $10,976 | $7,063 | 64.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 89 | 136 | $25,160 | $6,578 | 26.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 73 | 73 | $19,491 | $4,318 | 22.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 57 | 57 | $5,130 | $4,025 | 78.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $2,160 | $1,645 | 76.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 11 | 11 | $3,740 | $1,332 | 35.6% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 61 | 61 | $2,318 | $1,149 | 49.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 17 | 19 | $6,954 | $1,040 | 15.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 25 | 25 | $897.50 | $776.00 | 86.5% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 14 | 16 | $320.00 | $152.32 | 47.6% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 13 | 13 | $455.00 | $139.92 | 30.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 14 | 19 | $342.00 | $64.79 | 18.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 19 | 19 | $0.19 | $0.19 | 100.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 110 | 194 | $50,828 | $9,625 | 18.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 116 | 174 | $32,190 | $8,052 | 25.0% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 61 | 62 | $5,550 | $4,243 | 76.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 57 | 57 | $15,219 | $3,616 | 23.8% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $3,045 | $3,002 | 98.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 65 | 66 | $2,630 | $1,996 | 75.9% |
| G0442 | Annual alcohol misuse screening, 15 minutes | Office | 2022 | 64 | 64 | $2,432 | $1,235 | 50.8% |
| 0124A | Fee covid-19 vac 13 res | Office | 2022 | 26 | 26 | $2,080 | $1,041 | 50.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $6,222 | $717.72 | 11.5% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 19 | 19 | $652.10 | $577.16 | 88.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 15 | 16 | $560.00 | $174.96 | 31.2% |
About Dr. Philip Rosenblum, MD
Dr. Philip Rosenblum, MD is a Family Medicine healthcare provider based in Thornton, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1295732022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philip Rosenblum, MD has received a total of $19,181 in payments from pharmaceutical and medical device companies, with $2,605 received in 2024. These payments were reported across 1,190 transactions from 81 companies. The most common payment nature is "Food and Beverage" ($19,154).
As a Medicare-enrolled provider, Rosenblum has provided services to 2,438 Medicare beneficiaries, totaling 3,301 services with total Medicare billing of $166,720. Data is available for 4 years (2020–2023), covering 61 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Thornton, CO
- Active Since 07/07/2005
- Last Updated 05/05/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1295732022
Products in Payments
- VRAYLAR (Drug) $1,536
- JARDIANCE (Drug) $1,175
- FARXIGA (Drug) $1,089
- Ozempic (Drug) $729.72
- XARELTO (Drug) $615.35
- TRELEGY ELLIPTA (Drug) $550.60
- UBRELVY (Drug) $515.92
- NURTEC ODT (Drug) $514.13
- Kerendia (Drug) $406.03
- ENTRESTO (Drug) $404.89
- EMGALITY (Drug) $382.34
- INVOKANA (Drug) $353.23
- CHANTIX (Drug) $341.61
- ANORO (Drug) $314.95
- MOUNJARO (Drug) $311.42
- SYMBICORT (Drug) $300.00
- BREZTRI (Drug) $273.79
- QULIPTA (Drug) $248.54
- TRULICITY (Drug) $245.22
- Saxenda (Drug) $243.92
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Thornton
Dr. Kenneth Hahn, Do, DO
Family Medicine — Payments: $21,946
Family Medicine $21,946
Kent Schreiber, Md, MD
Family Medicine — Payments: $18,397
Family Medicine $18,397
Dr. Suzanne Nash, Md, MD
Family Medicine — Payments: $16,812
Family Medicine $16,812
James Weingart, Md, MD
Family Medicine — Payments: $13,329
Family Medicine $13,329
Ann Imhof, Md, MD
Family Medicine — Payments: $12,668
Family Medicine $12,668
Nancy Stoudt, Md, MD
Family Medicine — Payments: $10,008
Family Medicine $10,008